Literature DB >> 10604583

Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins.

B Kreymann1, M Seige, U Schweigart, K F Kopp, M Classen.   

Abstract

BACKGROUND: Acute liver failure may be the first manifestation of Wilson disease. If copper elimination fails, liver transplantation is the only remaining therapeutic option. Albumin dialysis, a new method for the removal of protein-bound toxins, was performed in a patient with fulminant Wilson disease.
METHODS: An 18-year-old man with Wilson disease presented with hyperacute liver failure, hepatic encephalopathy III, oligo-anuric renal failure, haemolytic anaemia, rhabdomyolysis, pancreatitis and thrombocytopenia. He was treated with albumin dialysis using a 44 g/l albumin-containing dialysate and a slow dialysate flow rate (1-2 l/h). The other details of the technique used are similar to routine continuous veno-venous haemodiafiltration.
RESULTS: One hundred and five milligrams of copper were removed by albumin dialysis within the first six treatments, resulting in normalisation of blood-copper levels. Successful treatment of the multiorgan failure was achieved. Hepatic encephalopathy improved within 2 days. The patient initially refused liver transplantation. Therefore 35 additional albumin dialysis treatments were performed. Forty-three grams of bilirubin (an indicator of detoxified substances in the liver) and 196 mg of copper were removed. Multiorgan failure, in particular hepatic encephalopathy, did not recur during 59 days of treatment. Eventually, the patient agreed to liver transplantation and that was successful.
CONCLUSION: Albumin dialysis is a new method for the effective treatment of fulminant Wilson disease, resulting in the removal of protein-bound toxins copper and bilirubin. It may serve as a new treatment option in hyperacute liver failure of other origin, acting as an extracorporeal detoxifier.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604583     DOI: 10.1016/s0168-8278(99)80322-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

Review 1.  Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological data.

Authors:  S Mitzner; J Loock; P Peszynski; S Klammt; J Majcher-Peszynska; A Gramowski; J Stange; R Schmidt
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

Review 2.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

Review 3.  [Liver replacement therapy. Reliable indications in acute liver failure].

Authors:  K Rifai; M Ott; M M Bahr; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 4.  Wilson's disease: update on integrated Chinese and Western medicine.

Authors:  Wen-Jie Li; Jun-Feng Wang; Xiao-Ping Wang
Journal:  Chin J Integr Med       Date:  2012-05-19       Impact factor: 1.978

5.  Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests.

Authors:  Jessica D Korman; Irene Volenberg; Jody Balko; Joe Webster; Frank V Schiodt; Robert H Squires; Robert J Fontana; William M Lee; Michael L Schilsky
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

6.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

7.  Plasma exchange for hemolytic crisis and acute liver failure in Wilson disease.

Authors:  Nishant Verma; Gautham Pai; Pankaj Hari; Rakesh Lodha
Journal:  Indian J Pediatr       Date:  2013-03-14       Impact factor: 1.967

8.  Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report.

Authors:  Katherine L Collins; Eve A Roberts; Khosrow Adeli; Desmond Bohn; Elizabeth A Harvey
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 9.  [Acute liver failure].

Authors:  K Rifai; M J Bahr
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

10.  Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.

Authors:  John F Patzer
Journal:  Artif Organs       Date:  2008-07       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.